Our previous study found that A-SeQDs can prevent endothelial dysfunction in high-fat and high-sugar rats by inhibiting NHE1 and has various protective effects on the cardiovascular system (Zhu et al., 2019). The gene discussed is SLC9A1; the disease is endothelial dysfunction.